
Articles
-
Jul 15, 2024 |
healio.com | Arshad Khanani |Anthony DeFino |David Mullin |Christine Klimanskis
You've successfully added to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. PARK CITY, Utah — In this Healio Video Perspective from Clinical Trials at the Summit, Arshad M. Khanani, MD, MA, FASRS,discusses efficacy and safety data for the port delivery system ahead of its reintroduction.
-
Jul 11, 2024 |
healio.com | Carlos Quezada-Ruiz |Anthony DeFino |David Mullin |Christine Klimanskis
You've successfully added to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. PARK CITY, Utah — In this Healio Video Perspective from Clinical Trials at the Summit, Carlos Quezada-Ruiz, MD, FASRS,of Genentech/Roche shares an update on Susvimo and the port delivery platform.
-
Jul 3, 2024 |
healio.com | Arshad Khanani |Anthony DeFino |David Mullin |Christine Klimanskis
You've successfully added Retina/Vitreous in Ophthalmology to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. PARK CITY, Utah — In this Healio Video Perspective from Clinical Trials at the Summit, Arshad M.
-
Jun 23, 2024 |
healio.com | Lori Taylor |Anthony DeFino |David Mullin |Christine Klimanskis
You've successfully added to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. PARK CITY, Utah — In this Healio Video Perspective from Clinical Trials at the Summit, Lori Taylor of Annexon Biosciences previews data on ANX007 for the treatment of geographic atrophy.
-
Jun 18, 2024 |
healio.com | David S. Boyer |Anthony DeFino |David Mullin |Christine Klimanskis
You've successfully added to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. PARK CITY, Utah — In this Healio Video Perspective from Clinical Trials at the Summit, David S.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →X (formerly Twitter)
- Followers
- 159
- Tweets
- 1K
- DMs Open
- No